Literature DB >> 22233302

A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study.

Tülin Kuyucu1, Salih Zeki Güçlü, Bengü Saylan, Cahit Demir, Tuncer Senol, Serdar Güner, Ejder Koyuncu, Ferit Ozen, Sezai Oztürk, Zeki Cangül, Semih Ağanoğlu, Sevket Ozkaya, Sevilay Ciçek Ocak, Hüseyin Akkurt, Yavuz Selim Intepe, Merve Gülcan Bayrak, Tuncay Güler, Taha Tahir Bekçi, Sadan Soyyiğit, Salim Seyfettin, Ozhan Kula, Makbule Ozlem Akbay, Bengü Büyükgöze, Gökhan Asal, Seyma Başlilar, Osman Oztürk.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a lung disease characterized with limitation of airflow that is not completely reversible, progressive deterioration of airways and systemic inflammation. This study has been planned to determine daily symptom variability of patients, expectations of patient and physicians from treatment and patient profiles. A total of 514 patients with COPD from 25 centers were included in this national, multicenter, cross-sectional observational study. Data regarding demographic features, concomitant diseases, history and treatment of COPD and expectations of patients and physicians were all obtained in a single visit. Mean [standard deviation (SD)] age of the patients was 64.1 (9.5) years; age range was 41-92 years, 50% of the patients were younger than 65 years and 91% were males. Educational level of the patients was at least primary school in 80.2%; and 54.3% (30.4%) of the patients had at least one concomitant disease, particularly a cardiovascular disease. Mean (SD) duration of having COPD was 5.4 (4.6) years. The majority of patients were at moderate (43.2%) and severe (35.0%) COPD stages and one or more exacerbations per year was determined in 71%. Inhaled beta-2 agonists (84.2%), inhaled steroids (76.3%) and inhaled long-acting anti-cholinergics (70.0%) were the most commonly used medications. Dyspnea (99.0%), sputum production (92.8%) and wheezing (90.5%) were the most common symptoms, and symptom variability for dyspnea (41.1%), sputum production (61.0%) and cough (53.5%) were seen the most in the morning hours (p< 0.001). Most commonly affected morning activity was climbing up/down the stairs (point of effect: 6.7), followed by wearing socks/shoes (point of effect: 4.3) and showering/bathing (point of effect: 4.2) by COPD. Major treatment expectations of patients were greater symptomatic relief (82.3%) and greater mobility (70.0%), faster symptomatic relief (61.1%) and improvement in morning activities (59.3%); while major treatment expectations of physicians included increased quality of life (100.0%) and decreased morbidity (96.0%). Quitting smoking was the most commonly recommended (88.3%) and implemented (67.9%) non-drug protective approach aimed at decreasing the frequency of exacerbations. Consequently, our results demonstrate that COPD is not a disease of only the elderly, is an important healthcare issue that often disrupt daily living of the patients due to inadequate disease awareness leading to overlooking of the symptoms by patient and physicians, and that a patient-centered approach based on the living standards, life expectancies and preferences of patients was crucial in patient management.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22233302     DOI: 10.5578/tt.3268

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  10 in total

1.  Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument.

Authors:  Jamuna K Krishnan; Kayley M Ancy; Clara Oromendia; Katherine L Hoffman; Imaani Easthausen; Nancy K Leidy; MeiLan K Han; Russell P Bowler; Stephanie A Christenson; David J Couper; Gerard J Criner; Jeffrey L Curtis; Mark T Dransfield; Nadia N Hansel; Anand S Iyer; Robert Paine Iii; Stephen P Peters; Jadwiga A Wedzicha; Prescott G Woodruff; Karla V Ballman; Fernando J Martinez
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29

2.  Perception of circadian variation of symptoms in Chinese patients with chronic obstructive pulmonary disease.

Authors:  Ming Lu; Xiaohong Wang; Baiqiang Cai; Kewu Huang; Jie Cao; Jinping Zheng; Yongchang Sun; Fuqiang Wen; Huili Zhu; Xin Zhou; Jianping Zhao; Yanfei Guo; Xia Ling; Wanzhen Yao
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.

Authors:  Judith J Stephenson; Qian Cai; Michelle Mocarski; Hiangkiat Tan; Jalpa A Doshi; Sean D Sullivan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-17

Review 4.  Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?

Authors:  F Blasi; G W Canonica; M Miravitlles
Journal:  Respir Res       Date:  2017-01-18

5.  Symptom variability over the course of the day in patients with stable COPD in Brazil: a real-world observational study.

Authors:  Alberto Cukier; Irma de Godoy; Claudia Henrique da Costa; Adalberto Sperb Rubin; Marcelo Gervilla Gregorio; Aldo Agra de Albuquerque Neto; Marina Andrade Lima; Monica Corso Pereira; Suzana Erico Tanni; Rodrigo Abensur Athanazio; Elizabeth Jauhar Cardoso Bessa; Fernando Cesar Wehrmeister; Cristina Bassi Lourenco; Ana Maria Baptista Menezes
Journal:  J Bras Pneumol       Date:  2019-12-20       Impact factor: 2.624

6.  Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary.

Authors:  N K Leidy; C C Sexton; P W Jones; S M Notte; B U Monz; L Nelsen; M Goldman; L T Murray; S Sethi
Journal:  Thorax       Date:  2014-03-04       Impact factor: 9.139

Review 7.  COPD symptoms in the morning: impact, evaluation and management.

Authors:  Nicolas Roche; Niels H Chavannes; Marc Miravitlles
Journal:  Respir Res       Date:  2013-10-21

Review 8.  Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease.

Authors:  Maria Gabriella Matera; Alessandro Sanduzzi; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-01-05

9.  Daytime symptoms of chronic obstructive pulmonary disease: a systematic review.

Authors:  Ioanna Tsiligianni; Janwillem W H Kocks
Journal:  NPJ Prim Care Respir Med       Date:  2020-02-21       Impact factor: 2.871

10.  The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD.

Authors:  Tian Sun; Xiaoyun Li; Wei Cheng; Yating Peng; Yiyang Zhao; Cong Liu; Yuqin Zeng; Yan Chen; Shan Cai; Ping Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.